(Q46152824)

English

A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity

scientific article published in September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

1 reference

PHPIZROJYXXSHW-XDEKXSDFSA-N

1 reference

author name string

Ryo Murakami

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Yoko Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Masaaki Kizuka

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Tomoka Kagawa

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Yasunori Muramatsu

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Shunichi Miyakoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Toshio Takatsu

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Masatoshi Inukai

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

publication date

September 2008

1 reference

16 September 2022

full work available at URL

https://www.nature.com/articles/ja200871.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.71?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

61

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

537-544

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.71?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

https://scigraph.springernature.com/pub.10.1038/ja.2008.71

0 references

Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

21 January 2018

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure of a new nucleoside antibiotic, capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on Novel Bacterial Translocase I Inhibitors, A-500359s. III. Deaminocaprolactam Derivatives of Capuramycin: A-500359 E, F, H, M-1 and M-2.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. V. Enhanced production of capuramycin and A-500359 A in Streptomyces griseus SANK 60196.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for characterization of Streptomyces species

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Biosynthesis of the tunicamycins: a review

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JA.2008.71

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46152824&oldid=2110333793"